Werewolf Therapeutics HOWL Cash Flow Statement (2020-2026)

NASDAQ HOWL
$0.98 +0.02 (+2.06%)
As of: Sep 10, 2026 · 3:08 PM EDT
Reported Financials

Werewolf Therapeutics Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Werewolf Therapeutics reported cash from operations of $6.63M and free cash flow of $6.63M for the quarter ended Jun 2026, up 143.7% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-13.74M-17.92M-15.33M-14.88M-11.95M-12.00M-10.88M-5.07M-8.28M-12.00M-16.19M-18.31M-16.77M-20.31M-18.26M-17.99M-16.37M-10.22M-14.21M6.96M
Share-based Compensation
1.48M10.86M1.75M1.78M1.94M1.94M2.11M1.93M2.10M1.87M2.31M2.60M2.01M1.91M2.01M1.79M1.23M1.21M0.93M0.42M
Cash from Operations
-12.42M-12.67M-13.95M-0.30M-14.47M-11.87M-9.90M-10.92M-7.21M-4.58M-15.30M-14.18M-12.46M-14.25M-18.95M-15.16M-15.16M-11.02M-10.60M6.63M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.38M0.58M0.30M0.14M0.34M0.34M0.54M0.36M0.38M0.17M0.17M0.18M0.19M0.19M0.20M0.21M0.22M0.09M
Amortization of Deferred Charges
0.20M0.06M
Change in Working Capital
Change in Account Payables
-1.51M0.65M-0.67M0.81M-0.91M-0.10M0.96M-0.62M-0.10M
Change in Accured Expenses
2.17M3.12M-2.03M5.56M1.15M-1.63M0.90M-3.92M-2.27M0.95M-2.47M2.48M0.85M2.59M-3.37M1.02M-1.21M-3.94M1.92M-0.22M
Other Working Capital Changes
0.84M-0.46M-1.79M4.51M0.67M-4.38M-1.43M0.42M-0.72M-0.36M-0.74M-0.34M-0.35M-0.17M-0.56M-0.39M-0.40M-0.21M-0.61M-2.77M
Investing Activities
Capital Expenditures
0.10M0.42M1.55M0.33M1.21M0.52M0.17M0.18M0.22M0.20M0.11M0.02M0.00M0.12M
Cash from Investing Activities
-0.10M-0.27M-0.03M-1.11M-1.95M-0.52M-0.17M-0.18M-0.22M-0.20M-0.11M-0.02M-0.00M-0.12M
Financing Activities
Other financing activities
0.16M0.00M0.07M0.02M0.04M0.05M0.01M0.06M0.07M0.04M0.05M
Debt Issuance and Repayment
Long-Term Debt Issuances
40.00M40.00M
Change in Capital Stock
Net Equity Issued and Repurchased
3.65M11.11M0.98M8.62M0.64M0.04M9.03M20.25M0.88M-0.03M2.48M0.35M3.27M2.32M
Misc.
Cash from Financing Activities
-0.28M0.04M0.16M3.42M11.08M1.26M48.62M0.69M0.04M9.07M20.26M-9.72M-0.01M2.55M0.39M3.27M2.37M
Change in Cash
-12.79M-12.91M-13.82M2.00M-5.35M-11.13M38.56M-10.41M-7.39M4.29M4.85M-23.91M-12.47M-11.83M-18.95M-14.78M-11.88M-8.66M-10.60M-25.37M
Free Cash Flow
-12.52M-13.10M-15.50M-0.63M-15.68M-12.39M-10.07M-11.10M-7.43M-4.78M-15.41M-14.19M-12.46M-14.38M-18.95M-15.16M-15.16M-11.02M-10.60M6.63M
Net Cash Flow
-12.79M-12.91M-13.82M2.00M-5.35M-11.13M38.56M-10.41M-7.39M4.29M4.85M-23.91M-12.47M-11.83M-18.95M-14.78M-11.88M-8.66M-10.60M6.63M